SEC Tracker
Get the app

Orchestra BioMed Holdings OBIO

Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed

Form
8-K
Filed
Importance
Routine
  • Signs a material agreement (1.01)
  • Takes on a new financial obligation (2.03)
  • Sells unregistered shares (3.02)
  • Makes a Regulation FD disclosure (7.01)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Orchestra BioMed Holdings files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. Myomo MYO public float $62M, Jun 30, 2025
  2. Edap TMS EDAP public float $62M, Jun 30, 2025
  3. InspireMD NSPR public float $61M, Jun 30, 2025
  4. Cytosorbents CTSO public float $61M, Jun 30, 2025
  5. Pro Dex PDEX public float $68M, Dec 31, 2025

Data on this page was fetched . The filing on SEC.gov is the record.